210 results on '"Osterziel, K"'
Search Results
2. Symbolic Dynamics
3. Angiotensin II und koronare Herzerkrankung, Herzinsuffizienz und plötzlicher Herztod
4. Therapie — Digitalis
5. Pathophysiologie — Hämodynamik und Reflexe
6. Pathophysiologie — Vasopressin-System
7. Epidemiologie
8. ACE-Hemmung als therapeutisches Prinzip
9. Evaluation of the Severity of Heart Failure: Role of Compensatory Mechanisms
10. Pathophysiologie — Renin-Angiotensin-Aldosteron-System
11. Kardiale Manifestationen bei Muskeldystrophien
12. Genetik der dilatativen Kardiomyopathie
13. Aktueller Stand der Therapie der chronischen Herzinsuffizienz
14. Growth hormone therapy in heart failure
15. Duale Sequenzmethode zur Analyse der spontanen Baroreflexsensitivität bei Patienten mit dilatativer Kardiomyopathie
16. Therapie der dilatativen Kardiomyopathie mit rekombinantem humanem Wachstumshormon
17. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy: 203
18. Expression of calcium channel subunits in the normal and diseased human myocardium
19. Vernetzte Spitzenforschung in der Kardiologie—das Kompetenznetz Herzinsuffizienz1: Im Rahmen des Gesundheitsforschungsprogramms „Kompetenznetze in der Medizin“ gibt es seit 2003 das Kompetenznetz Herzinsuffizienz
20. A new LMNA mutation causing limb girdle muscular dystrophy 1B
21. Symbolic Dynamics
22. Clinical and genetic characteristics of α cardiac actin gene mutations in hypertrophic cardiomyopathy
23. Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period
24. Erratum: Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy (Human Molecular Genetics (2008) vol. 17 (18) (2753-2765) 10.1093/hmg/ddn160)
25. Clinical and genetic characteristics of alpha cardiac actin gene mutations in hypertrophic cardiomyopathy
26. Duale Sequenzmethode zur Analyse der spontanen Barorezeptorsensitivität
27. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy
28. Primärer Hyperaldosteronismus ohne arterielle Hypertonie
29. Hypotonierisiko bei Therapie der Herzinsuffizienz mit Konversionsenzym-Hemmern
30. Therapie der Herzinsuffizienz mit ACE-Hemmern
31. Insulin-like growth factor-binding proteins 2 and 3 are independent predictors of a poor prognosis in patients with dilated cardiomyopathy
32. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1 year results of the REPAIR-AMI trial
33. Composite polymorphisms in the ryanodine receptor 2 gene associated with arrhythmogenic right ventricular cardiomyopathy
34. 387 Relation of myocardial repolarisation and conduction to diastolic function and left ventricular hypertrophy in hypertensive patients
35. 302 Clinical aspects of familial dilated cardiomayopathy — the Berlin experience
36. 397 Heart rate variability correlates with symptoms of heart failure in patients with diastolic dysfunction
37. 304 A combination of single nucleotide plymorphisms of the human cardiac ryanodine receptor (RyR2) is associated with arrhythmogenic right ventricular cardiomyopathy
38. 287 Novel mutation in the TCAP gene encoding titin-cap/telethonin in a family with hypertrophic cardiomyopathy
39. Der plötzliche Herztod bei familiärer hypertropher Kardiomyopathie
40. Expression profiling of human idiopathic dilated cardiomyopathy
41. 202 Familial hypertrophic cardiomyopathy caused by myosin head domain mutations: investigation of functional effects and expression of mutated protein
42. 150 Angiotensin I converting enzyme 2 and dilated cardiomyopathy - association of the 8790G>A polymorphism with left ventricular ejection fraction
43. 83 In vitro analysis of the functional impact of a MLP missense mutation associated with hypertrophic cardiomyopathy
44. Aneurysma der Vena poplitea als Ursache rezidivierender Lungenarterienembolien mit Reanimationspflichtigkeit
45. Cardiac hypertrophy in Friedreich's ataxia
46. Nachlast und Blutdruckamplitude bei dilatativer Kardiomyopathie. Afterload and Blood Pressure Amplitude in Dilated Cardiomyopathy
47. The Severity of Chronic Heart Failure due to Coronary Artery Disease Predicts the Endocrine Effects of Short- Term Growth Hormone Administration
48. Role of nitric oxide in the vasodilator effect of recombinant human growth hormone in patients with dilated cardiomyopathy
49. Dual sequence method for analysis of the spontaneous baroreceptor sensitivity in patients with dilated cardiomyopathy
50. Ventricular Remodeling after Acute Myocardial Infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.